A Case of Pediatric Guillain-Barré Syndrome After Respiratory Syncytial Virus Infection

Megan Gupta1, Sanaz Monjazeb1, Tena Rosser2

  • 1Division of Neurology, Children's Hospital Los Angeles, Los Angeles, California.

Pediatric Neurology
|July 23, 2023
PubMed

Insights

A rare case of Guillain-Barré syndrome in a toddler was initially masked by respiratory syncytial virus bronchiolitis. This highlights the importance of considering neurological conditions in young children with respiratory symptoms.

Area of Science:

  • Pediatric Neurology
  • Infectious Diseases
  • Demyelinating Disorders

Background:

  • Guillain-Barré syndrome (GBS) is an autoimmune disorder affecting the peripheral nervous system.
  • Postinfectious demyelinating disorders are increasingly recognized in pediatric populations.
  • Respiratory infections are common triggers for neurological complications in children.

Observation:

  • A two-year-old girl presented with progressive lower extremity weakness.
  • The weakness was initially obscured by symptoms of respiratory syncytial virus (RSV) bronchiolitis.
  • Diagnosis of GBS was established in the context of the viral respiratory illness.

Findings:

  • This case illustrates a unique presentation of GBS in a very young child.
  • The neurological symptoms were masked by a prominent respiratory condition.
  • The specific viral trigger for GBS in this case was respiratory syncytial virus.

Implications:

  • This case expands the understanding of GBS and postinfectious demyelinating disorders in early childhood.
  • It emphasizes the need for heightened clinical suspicion for neurological conditions presenting with respiratory symptoms in toddlers.
  • The findings suggest that pediatric GBS may not always be linked to specific antigenic triggers, broadening the scope of potential causes.

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.6K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
278
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
250
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
348
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
165
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
227